Inventor · disambiguated record
Marinus Leendert Verdonk
Also filed as: VERDONK MARINUS LEENDERT
5 granted patents·8 pending applications·9 citations·filing 2004–2016
71Inventor score
Top patents by PatentIndex Score
13 records- 0177US10364256B2Biaryl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 30, 2019·2 cites·15 claims
- 0276US8691806B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 0373US8247576B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2004·Granted Aug 21, 2012·5 cites·8 claims
- 0462US9283226B2Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 0553US2016250187A1Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 0647US2010093748A1Substituted piperidines having protein kinase inhibiting activityASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 0746US2010120798A1Substituted piperidines containing a heteroarylamide or heteroarylphenyl moietyASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 0845US2009124610A1Pharmaceutical compoundsSAXTY GORDON·Filed 2007·Application pending·0 cites
- 0945US2010016340A1Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 1043US2010210617A1Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase InhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 1142US2008275029A1Compounds for Treating Protein-Kinase Mediated DisordersASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 1241US2009099213A1Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 1337US10351530B2Arylcyclohexyl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 16, 2019·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →